Price T Rowe Associates Inc. MD Has $246,000 Position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Price T Rowe Associates Inc. MD grew its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 5.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 53,699 shares of the company’s stock after buying an additional 2,649 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Aveanna Healthcare were worth $246,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in AVAH. Barclays PLC raised its position in shares of Aveanna Healthcare by 80.1% in the 3rd quarter. Barclays PLC now owns 122,689 shares of the company’s stock valued at $637,000 after buying an additional 54,557 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Aveanna Healthcare by 266.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company’s stock valued at $446,000 after purchasing an additional 62,319 shares during the last quarter. SG Americas Securities LLC grew its holdings in shares of Aveanna Healthcare by 26.0% during the 4th quarter. SG Americas Securities LLC now owns 24,366 shares of the company’s stock valued at $111,000 after purchasing an additional 5,031 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Aveanna Healthcare by 15.7% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company’s stock valued at $115,000 after purchasing an additional 3,407 shares during the last quarter. Finally, Legato Capital Management LLC bought a new stake in shares of Aveanna Healthcare during the 4th quarter valued at approximately $83,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Price Performance

AVAH opened at $5.99 on Friday. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.32 and a fifty-two week high of $6.19. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of -17.62 and a beta of 2.01. The company’s 50 day moving average price is $5.04 and its two-hundred day moving average price is $4.92.

Insiders Place Their Bets

In other news, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the business’s stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $5.84, for a total value of $531,796.24. Following the transaction, the insider now owns 545,330 shares in the company, valued at approximately $3,184,727.20. The trade was a 14.31% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 47,039 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $5.72, for a total transaction of $269,063.08. Following the completion of the transaction, the insider now owns 1,447,191 shares in the company, valued at $8,277,932.52. This trade represents a 3.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 205,512 shares of company stock valued at $1,173,001 in the last ninety days. 7.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AVAH. UBS Group lifted their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a report on Friday, May 9th. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a report on Friday, April 11th.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.